GSK Consumer Healthcare deploys Thinfilm smart shelf tags with Flonase

Press enter to search
Close search
Open Menu

GSK Consumer Healthcare deploys Thinfilm smart shelf tags with Flonase

By Michael Johnsen - 10/03/2017

OSLO, Norway — Thinfilm Electronics on Tuesday announced GSK Consumer Healthcare has commercially deployed Thinfilm’s SpeedTap tags to create interactive ‘smart’ shelves for enhanced communication with consumers at time of purchase decision-making in Canada.


“Connecting directly with consumers to provide unique and meaningful experiences is critical in today’s market,” stated Sriman Banerjee, director R&D respiratory packaging for GSK Consumer Healthcare. “We believe an innovative mobile technology like Thinfilm’s can play a critical role in strengthening customer relationships, building brand loyalty and driving revenue for the Flonase brand.”



GSK Consumer Healthcare introduced interactive ‘smart’ Flonase shelves in retail stores across Canada in an effort to educate consumers about the new product and guide them in their purchasing decision. Thinfilm’s unique SpeedTap tags incorporated into shelving allows consumers to obtain product information through the tap of an NFC-enabled smartphone.



In addition to SpeedTap tags, GSK Consumer Healthcare also is using Thinfilm’s software platform, CNECT, as part of the end-to-end solution that helps dynamically manage the experience of Flonase consumers. The cloud-based platform integrates with the NFC hardware, enabling GlaxoSmithKline to manage tags remotely, deliver custom messaging and content, view real-time consumer tapping activity and develop valuable consumer insights through built-in analytics functionality.



Flonase Allergy Relief is the first ‘prescription to over-the-counter’ intranasal corticosteroid spray from GSK Consumer Healthcare indicated for relief of nasal and eye-related allergy symptoms as well as management of sinus pain and pressure. It is an effective medicine that relieves seasonal and year-round allergy symptoms caused by pollen, mold, dust and pets.



“Bringing Thinfilm’s NFC solutions to a valued product like Flonase is a milestone in the industry, and we look forward to helping [GSK Consumer Healthcare] drive the brand’s value by connecting directly with consumers at the time of purchase decision-making,” commented Davor Sutija, CEO Thinfilm.



 


Related Topics